| 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|
| Gross margin | 115,6 k € | +117.7% | 53,1 k € | -69.8% | 176,0 k € | |
| EBITDA | 56,6 k € | +13.8% | 49,7 k € | -41.8% | 85,5 k € | |
| Operating profit | 52,2 k € | +8.4% | 48,2 k € | -39.5% | 79,7 k € | |
| Profit/loss | 41,5 k € | -8.9% | 45,6 k € | -8.0% | 49,5 k € | |
| Equity | 139,8 k € | +42.3% | 98,3 k € | +88.9% | 52,0 k € | |
| Total assets | 159,7 k € | +49.0% | 107,2 k € | +82.0% | 58,9 k € | |
| Cash | 83,5 k € | +71.4% | 48,7 k € | +404.8% | 9,6 k € | |
| Debts | 19,9 k € | +153.9% | 7,8 k € | +35.8% | 5,8 k € | |
Private limited company · Uccle · incorporated on 21/12/2020
Private limited company profitable and well capitalised. Cash position rising (+71.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
SARAH INFI is a Private limited company incorporated in 2020. Its main activity is: Other human health activities. Its registered office is in Uccle.